Marijn Verhoef

Marijn Verhoef is Director of Operations and Research at the Access to Medicine Foundation. Marijn oversees implementation of strategy, tracking of the Foundation’s progress and internal alignment. Furthermore, he is responsible for the Foundation’s research teams, who translate access-to-medicine developments by essential healthcare companies into actionable opportunities. Marijn keeps oversight of the current and future research programmes of the Foundation.
Marijn is a pharmacist by training, holding a Master’s degree in Pharmaceutical Sciences from Utrecht University in the Netherlands, where he completed a thesis on medication-related hospital admissions.
Before joining the Foundation, Marijn spent more than 5 years working in marketing and medical affairs in a multinational pharmaceutical company in roles relating to immunology and infectious diseases. Marijn worked at the Foundation as a Researcher, before heading the Company Engagement team for four years.
Marijn Verhoef is Director of Operations and Research at the Access to Medicine Foundation. Marijn oversees implementation of strategy, tracking of the Foundation’s progress and internal alignment. Furthermore, he is responsible for the Foundation’s research teams, who translate access-to-medicine developments by essential healthcare companies into actionable opportunities. Marijn keeps oversight of the current and future research programmes of the Foundation.
Marijn is a pharmacist by training, holding a Master’s degree in Pharmaceutical Sciences from Utrecht University in the Netherlands, where he completed a thesis on medication-related hospital admissions.
Before joining the Foundation, Marijn spent more than 5 years working in marketing and medical affairs in a multinational pharmaceutical company in roles relating to immunology and infectious diseases. Marijn worked at the Foundation as a Researcher, before heading the Company Engagement team for four years.
Articles: Marijn Verhoef
Faced with Fewer Superbug-Beating Drugs, how can Pharma get More Promising Medicines to Patients?
Global / Marijn Verhoef, Director of Operations and Research at the Access to Medicine Foundation examines the interconnected challenges of drug shortages and antimicrobial resistance. Verhoef urges decisive and urgent action from the pharma companies that manufacture lifesaving antibiotics and antifungals to ensure that patients can get the right medicine when they need it most. A…